Keyphrases
Visual Acuity
100%
Intravitreal Ranibizumab
86%
Surgical Outcomes
77%
Macular Edema
68%
Aqueous Flare
57%
Pigmented Rabbit
57%
Age-related Macular Degeneration
50%
Vitreoretinal Surgery
46%
Branch Retinal Vein Occlusion
43%
Prostaglandin E2
43%
Macular Hole
35%
Internal Limiting Membrane
35%
Best-corrected Visual Acuity
34%
Optical Coherence Tomography
34%
After Surgery
33%
Central Macular Thickness
29%
Corneal Perforation
28%
Betaxolol
28%
Japanese Patients
28%
Photodynamic Therapy
28%
Older Women
26%
Glaucoma Implant Surgery
22%
Baerveldt Glaucoma Implant
22%
Vitrectomy
21%
Visual Outcome
21%
Gas Tamponade
21%
Amniotic Membrane
20%
University Hospital
19%
Intraocular Pressure
19%
Tissue Adhesive
19%
Macula
17%
Retinal Detachment
17%
Inverted Internal Limiting Membrane Flap
17%
Internal Limiting Membrane Peeling
17%
Receptor Subtypes
17%
Selective Agonist
17%
Highly Selective
17%
Ocular Findings
16%
Left Eye
16%
Type 2 Diabetes Mellitus (T2DM)
16%
Edema
16%
Pars Plana Vitrectomy
15%
Vitreous Cavity
15%
Subconjunctival Hemorrhage
14%
Macular Grid Laser Photocoagulation
14%
Posterior Staphyloma
14%
G System
14%
Aphakia
14%
Ocular Toxoplasmosis
14%
Diabetic Macular Edema
14%
Medicine and Dentistry
Visual Acuity
82%
Vitreous
77%
Macular Hole
63%
Macular Edema
50%
Prostaglandin E2
43%
Retinal Detachment
43%
Optical Coherence Tomography
34%
Glaucoma
29%
Branch Retinal Vein Occlusion
28%
Intravitreal Administration
28%
Corneal Perforation
28%
Amnion
28%
Betaxolol
28%
Bevacizumab
28%
Tamponade
27%
Retrospective Study
24%
Intraocular Lens
23%
Intraocular Pressure
20%
Edema
20%
Vitrectomy
20%
Tissue Adhesive
18%
Recurrent Disease
16%
Receptor Subtype
16%
Iris
16%
Pars Plana Vitrectomy
16%
Maturity Onset Diabetes of the Young
16%
Best Corrected Visual Acuity
15%
Subconjunctival Hemorrhage
14%
Implant
14%
Staphyloma
14%
Aphakia
14%
Diabetic Macular Edema
14%
Optical Coherence Tomography Angiography
14%
Unoprostone Isopropyl Ester
14%
Coloboma
14%
Anterior Chamber of Eyeball
14%
Retinoschisis
14%
Proliferative Retinopathy
14%
Iganidipine
14%
Carotid-Cavernous Fistula
14%
Elbow
14%
Laser Coagulation
14%
Endothelial Cell
14%
High Myopia
14%
Down Syndrome
14%
Epiretinal Membrane
14%
Choroidal Neovascularization
14%
Chemokine
14%
Insulin Treatment
14%
N [bis(1 Aziridinyl)phosphinyl] 4 Iodobenzamide
14%
Pharmacology, Toxicology and Pharmaceutical Science
Intravitreal Administration
69%
Macular Edema
67%
Bevacizumab
57%
Age Related Macular Degeneration
50%
Branch Retinal Vein Occlusion
43%
Pigmented Rabbit
43%
Betaxolol
28%
Ranibizumab
28%
Photodynamic Therapy
28%
Prostaglandin E2
28%
Retina Macula Hole
28%
Receptor Subtype
16%
Recurrent Disease
15%
Cornea Perforation
14%
Bleeding
14%
Ocular Toxoplasmosis
14%
Subretinal Neovascularization
14%
Proliferative Retinopathy
14%
Iganidipine
14%
Central Retina Vein Occlusion
14%
Vitreoretinopathy
14%
Chemokine
14%
Diabetic Retinopathy
14%
Non Insulin Dependent Diabetes Mellitus
14%
Seasonal Allergic Conjunctivitis
14%
Pear
14%
Diabetes Mellitus
13%
Vasculotropin
12%
Retrospective Study
9%
RANTES
9%
Brolucizumab
7%
Chorioretinopathy
7%
Blurred Vision
7%
Prednisolone
7%
Toxoplasma gondii
7%
Retinopathy
7%
Diabetic Complication
7%
Clindamycin
7%
Retina Maculopathy
7%
Polypoidal Choroidal Vasculopathy
7%
Neovascularization (Pathology)
7%
Aflibercept
7%
Immunoglobulin G
7%
Leporidae
6%
Tissue Adhesive
6%
Collagenase
6%